Nonclinical Expert, Ground Zero Pharmaceuticals, Inc.
Member of the Healthcare Council
Duane Lakings, PhD, is a Nonclinical Expert in Pharmacology, Pharmacokinetic, and Toxicology at Ground Zero Pharmaceuticals in Irvine, CA. Dr. Lakings is also Principal and President at Drug Safety Evaluation Consulting. He has over 30 years of experience in conducting and reporting results from drug discovery, developability assessment, and drug development experiments and for the past 20 years has been involved in selecting and managing nonclinical research studies outsourced to CROs. He received a Ph.D. in bioanalytical chemistry and has held scientific and managerial positions at pharmaceutical and biotechnology companies and CROs. His responsibilities have included designing and conducting bioanalytical chemistry, pharmacokinetic, drug metabolism, and drug delivery experiments in animal models and in humans and in directing and collaborating with other scientists in the various disciples required for successful drug development. Dr. Lakings has authored 43 publications, 11 commissioned reports, 6 book chapters, and over 200 company-specific technical reports and has written the nonclinical sections for INDs, yearly updates, and marketing applications. Thus, he has experience in the design and implementation of research studies necessary for the characterization and development of drug candidates and in scientific document preparation to support regulatory submissions. (This is me - Update Profile)
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
Duane Lakings has not published any GLG News Analyses.